A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population Publication Zilovertamab Vedotin 在血液恶性肿瘤患者中的序贯群体药代动力学模型推断至儿童群体 Certara2024 年 11 月 7 日
Model-Informed Confidence in Oncology Dose Selection Case Study 肿瘤学剂量选择中模型引导的决策信心 Discover an oncology-focused company that gained confidence in their dose selection for an AML trial…Certara2024 年 8 月 9 日
